Spyre Therapeutics, Inc. - Common Stock (SYRE) stock analysis

SYRE · Spyre Therapeutics, Inc. - Common Stock

Latest recorded price: USD 99.37

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -100.0%.

Similar companies in Healthcare